![David L. Corbet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Craig Jalbert | M | 63 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | 4 ans |
Patricia Randall | F | 72 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
T. Stephen Thompson | M | 76 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | 18 ans |
Jonathan M. Niloff | M | 70 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
Bruce Lehman | M | 74 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
Keith D. Lowey | M | 61 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | 4 ans |
C. William Zadel | M | 80 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
Robert Rosenthal | M | 67 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
Stephen D. Chubb | M | 80 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
David Musket | M | 66 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
Judith Kurland | F | 78 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
Richard Sandberg | M | 80 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | 9 ans |
Walter O. Fredericks | M | 84 |
MZT Holdings, Inc.
![]() MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 13 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- David L. Corbet
- Réseau Personnel